302 related articles for article (PubMed ID: 16478428)
1. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma.
Upton ML; Tangner CH; Payton ME
J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
[TBL] [Abstract][Full Text] [Related]
3. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study.
Poirier VJ; Forrest LJ; Adams WM; Vail DM
J Am Anim Hosp Assoc; 2004; 40(2):131-6. PubMed ID: 15007049
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma.
Henry CJ; McCaw DL; Turnquist SE; Tyler JW; Bravo L; Sheafor S; Straw RC; Dernell WS; Madewell BR; Jorgensen L; Scott MA; Higginbotham ML; Chun R
Clin Cancer Res; 2003 Feb; 9(2):906-11. PubMed ID: 12576466
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993).
Chun R; Knapp DW; Widmer WR; Glickman NW; DeNicola DB; Bonney PL
J Am Vet Med Assoc; 1996 Nov; 209(9):1588-91. PubMed ID: 8899023
[TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs.
Robat C; Burton J; Thamm D; Vail D
J Small Anim Pract; 2013 Feb; 54(2):67-74. PubMed ID: 23286739
[TBL] [Abstract][Full Text] [Related]
7. Palliative ultrasound-guided endoscopic diode laser ablation of transitional cell carcinomas of the lower urinary tract in dogs.
Cerf DJ; Lindquist EC
J Am Vet Med Assoc; 2012 Jan; 240(1):51-60. PubMed ID: 22171755
[TBL] [Abstract][Full Text] [Related]
8. Placement of a permanent cystostomy catheter to relieve urine outflow obstruction in dogs with transitional cell carcinoma.
Smith JD; Stone EA; Gilson SD
J Am Vet Med Assoc; 1995 Feb; 206(4):496-9. PubMed ID: 7768700
[TBL] [Abstract][Full Text] [Related]
9. Total cystectomy for treatment of transitional cell carcinoma of the urethra and bladder trigone in a dog.
Boston S; Singh A
Vet Surg; 2014 Mar; 43(3):294-300. PubMed ID: 24433358
[TBL] [Abstract][Full Text] [Related]
10. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004).
Wilson HM; Chun R; Larson VS; Kurzman ID; Vail DM
J Am Vet Med Assoc; 2007 Jul; 231(1):101-6. PubMed ID: 17605672
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.
Allstadt SD; Rodriguez CO; Boostrom B; Rebhun RB; Skorupski KA
J Vet Intern Med; 2015 Jan; 29(1):261-7. PubMed ID: 25619518
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder.
Marvel SJ; Séguin B; Dailey DD; Thamm DH
Vet Comp Oncol; 2017 Dec; 15(4):1417-1427. PubMed ID: 28217972
[TBL] [Abstract][Full Text] [Related]
13. A technique for resection of invasive tumors involving the trigone area of the bladder in dogs: preliminary results in two dogs.
Saulnier-Troff FG; Busoni V; Hamaide A
Vet Surg; 2008 Jul; 37(5):427-37. PubMed ID: 18986309
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of outcome following urethral stent placement for the treatment of obstructive carcinoma of the urethra in dogs: 42 cases (2004-2008).
Blackburn AL; Berent AC; Weisse CW; Brown DC
J Am Vet Med Assoc; 2013 Jan; 242(1):59-68. PubMed ID: 23234283
[TBL] [Abstract][Full Text] [Related]
15. Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.
Marconato L; Zini E; Lindner D; Suslak-Brown L; Nelson V; Jeglum AK
J Am Vet Med Assoc; 2011 Apr; 238(8):1004-10. PubMed ID: 21492043
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer.
Knapp DW; Glickman NW; Widmer WR; DeNicola DB; Adams LG; Kuczek T; Bonney PL; DeGortari AE; Han C; Glickman LT
Cancer Chemother Pharmacol; 2000; 46(3):221-6. PubMed ID: 11021739
[TBL] [Abstract][Full Text] [Related]
17. Carbon dioxide laser ablation combined with doxorubicin hydrochloride treatment for vaginal fibrosarcoma in a dog.
Peavy GM; Rettenmaier MA; Berns MW
J Am Vet Med Assoc; 1992 Jul; 201(1):109-10. PubMed ID: 1644628
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of mitoxantrone for the treatment of lymphoma in dogs.
Moore AS; Ogilvie GK; Ruslander D; Rand WS; Cotter SM; Getzy DM; L'Heureux DA; Dennis RA
J Am Vet Med Assoc; 1994 Jun; 204(12):1903-5. PubMed ID: 8077132
[TBL] [Abstract][Full Text] [Related]
19. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder.
Knapp DW; Richardson RC; Chan TC; Bottoms GD; Widmer WR; DeNicola DB; Teclaw R; Bonney PL; Kuczek T
J Vet Intern Med; 1994; 8(4):273-8. PubMed ID: 7983623
[TBL] [Abstract][Full Text] [Related]
20. Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma.
Schrempp DR; Childress MO; Stewart JC; Leach TN; Tan KM; Abbo AH; de Gortari AE; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2013 Jun; 242(11):1534-8. PubMed ID: 23683018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]